Selected research
Market Structure
Global Medicinal Low Borosilicate Glass Tubes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Medicinal Low Borosilicate Glass Tubes market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Medicinal Low Borosilicate Glass Tubes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medicinal Low Borosilicate Glass Tubes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medicinal Low Borosilicate Glass Tubes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medicinal Low Borosilicate Glass Tubes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medicinal Low Borosilicate Glass Tubes include Corning, Schott, Antylia, DWK Life Sciences, GSC International, Borosil, Nipro, Linuo and Shandong Pharmaceutical Glass, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Medicinal Low Borosilicate Glass Tubes market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medicinal Low Borosilicate Glass Tubes and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medicinal Low Borosilicate Glass Tubes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medicinal Low Borosilicate Glass Tubes market size, projected growth trends, production technologies, key applications, and end-use industries.
Medicinal Low Borosilicate Glass Tubes Segment by Company
Corning
Schott
Antylia
DWK Life Sciences
GSC International
Borosil
Nipro
Linuo
Shandong Pharmaceutical Glass
Chongqing Zhengchuan Pharmaceutical Packaging
Chongqing Beiyuan Glass
Taian Youlyy Industrial
Chongqing Wanzhou Shenyu Medicinal Glass
Puyang Xinhe Industry Development
Medicinal Low Borosilicate Glass Tubes Segment by Type
Transparent
Amber
Medicinal Low Borosilicate Glass Tubes Segment by Application
Common antibiotic controlled injections
Oral liquid
Others
Medicinal Low Borosilicate Glass Tubes Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medicinal Low Borosilicate Glass Tubes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medicinal Low Borosilicate Glass Tubes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medicinal Low Borosilicate Glass Tubes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Medicinal Low Borosilicate Glass Tubes market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medicinal Low Borosilicate Glass Tubes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medicinal Low Borosilicate Glass Tubes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Medicinal Low Borosilicate Glass Tubes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Transparent
- Amber
Applications
- Common antibiotic controlled injections
- Oral liquid
- Others
Companies covered
- Corning
- Schott
- Antylia
- DWK Life Sciences
- GSC International
- Borosil
- Nipro
- Linuo
- Shandong Pharmaceutical Glass
- Chongqing Zhengchuan Pharmaceutical Packaging
- Chongqing Beiyuan Glass
- Taian Youlyy Industrial
- Chongqing Wanzhou Shenyu Medicinal Glass
- Puyang Xinhe Industry Development
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medicinal Low Borosilicate Glass Tubes Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medicinal Low Borosilicate Glass Tubes Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Medicinal Low Borosilicate Glass Tubes Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Medicinal Low Borosilicate Glass Tubes Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Medicinal Low Borosilicate Glass Tubes Market Dynamics
- 2.1 Medicinal Low Borosilicate Glass Tubes Industry Trends
- 2.2 Medicinal Low Borosilicate Glass Tubes Industry Drivers
- 2.3 Medicinal Low Borosilicate Glass Tubes Industry Opportunities and Challenges
- 2.4 Medicinal Low Borosilicate Glass Tubes Industry Restraints
3 Medicinal Low Borosilicate Glass Tubes Market by Manufacturers
- 3.1 Global Medicinal Low Borosilicate Glass Tubes Revenue by Manufacturers (2021-2026)
- 3.2 Global Medicinal Low Borosilicate Glass Tubes Sales by Manufacturers (2021-2026)
- 3.3 Global Medicinal Low Borosilicate Glass Tubes Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Medicinal Low Borosilicate Glass Tubes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medicinal Low Borosilicate Glass Tubes Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Medicinal Low Borosilicate Glass Tubes Manufacturers, Product Type & Application
- 3.7 Global Medicinal Low Borosilicate Glass Tubes Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Medicinal Low Borosilicate Glass Tubes Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Medicinal Low Borosilicate Glass Tubes Players Market Share by Revenue in 2025
- 3.8.3 2025 Medicinal Low Borosilicate Glass Tubes Tier 1, Tier 2, and Tier 3
4 Medicinal Low Borosilicate Glass Tubes Market by Type
- 4.1 Medicinal Low Borosilicate Glass Tubes Type Introduction
- 4.1.1 Transparent
- 4.1.2 Amber
- 4.2 Global Medicinal Low Borosilicate Glass Tubes Sales by Type
- 4.2.1 Global Medicinal Low Borosilicate Glass Tubes Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medicinal Low Borosilicate Glass Tubes Sales by Type (2021-2032)
- 4.2.3 Global Medicinal Low Borosilicate Glass Tubes Sales Market Share by Type (2021-2032)
- 4.3 Global Medicinal Low Borosilicate Glass Tubes Revenue by Type
- 4.3.1 Global Medicinal Low Borosilicate Glass Tubes Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Medicinal Low Borosilicate Glass Tubes Revenue by Type (2021-2032)
- 4.3.3 Global Medicinal Low Borosilicate Glass Tubes Revenue Market Share by Type (2021-2032)
5 Medicinal Low Borosilicate Glass Tubes Market by Application
- 5.1 Medicinal Low Borosilicate Glass Tubes Application Introduction
- 5.1.1 Common antibiotic controlled injections
- 5.1.2 Oral liquid
- 5.1.3 Others
- 5.2 Global Medicinal Low Borosilicate Glass Tubes Sales by Application
- 5.2.1 Global Medicinal Low Borosilicate Glass Tubes Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medicinal Low Borosilicate Glass Tubes Sales by Application (2021-2032)
- 5.2.3 Global Medicinal Low Borosilicate Glass Tubes Sales Market Share by Application (2021-2032)
- 5.3 Global Medicinal Low Borosilicate Glass Tubes Revenue by Application
- 5.3.1 Global Medicinal Low Borosilicate Glass Tubes Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Medicinal Low Borosilicate Glass Tubes Revenue by Application (2021-2032)
- 5.3.3 Global Medicinal Low Borosilicate Glass Tubes Revenue Market Share by Application (2021-2032)
6 Global Medicinal Low Borosilicate Glass Tubes Sales by Region
- 6.1 Global Medicinal Low Borosilicate Glass Tubes Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medicinal Low Borosilicate Glass Tubes Sales by Region (2021-2032)
- 6.2.1 Global Medicinal Low Borosilicate Glass Tubes Sales by Region (2021-2026)
- 6.2.2 Global Medicinal Low Borosilicate Glass Tubes Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medicinal Low Borosilicate Glass Tubes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Medicinal Low Borosilicate Glass Tubes Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Medicinal Low Borosilicate Glass Tubes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Medicinal Low Borosilicate Glass Tubes Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Medicinal Low Borosilicate Glass Tubes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Medicinal Low Borosilicate Glass Tubes Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Medicinal Low Borosilicate Glass Tubes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Medicinal Low Borosilicate Glass Tubes Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Medicinal Low Borosilicate Glass Tubes Revenue by Region
- 7.1 Global Medicinal Low Borosilicate Glass Tubes Revenue by Region
- 7.1.1 Global Medicinal Low Borosilicate Glass Tubes Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Medicinal Low Borosilicate Glass Tubes Revenue by Region (2021-2026)
- 7.1.3 Global Medicinal Low Borosilicate Glass Tubes Revenue by Region (2027-2032)
- 7.1.4 Global Medicinal Low Borosilicate Glass Tubes Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Medicinal Low Borosilicate Glass Tubes Revenue (2021-2032)
- 7.2.2 North America Medicinal Low Borosilicate Glass Tubes Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Medicinal Low Borosilicate Glass Tubes Revenue (2021-2032)
- 7.3.2 Europe Medicinal Low Borosilicate Glass Tubes Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Medicinal Low Borosilicate Glass Tubes Revenue (2021-2032)
- 7.4.2 Asia-Pacific Medicinal Low Borosilicate Glass Tubes Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Medicinal Low Borosilicate Glass Tubes Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Medicinal Low Borosilicate Glass Tubes Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Corning
- 8.1.1 Corning Company Information
- 8.1.2 Corning Business Overview
- 8.1.3 Corning Medicinal Low Borosilicate Glass Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Corning Medicinal Low Borosilicate Glass Tubes Product Portfolio
- 8.1.5 Corning Recent Developments
- 8.2 Schott
- 8.2.1 Schott Company Information
- 8.2.2 Schott Business Overview
- 8.2.3 Schott Medicinal Low Borosilicate Glass Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Schott Medicinal Low Borosilicate Glass Tubes Product Portfolio
- 8.2.5 Schott Recent Developments
- 8.3 Antylia
- 8.3.1 Antylia Company Information
- 8.3.2 Antylia Business Overview
- 8.3.3 Antylia Medicinal Low Borosilicate Glass Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Antylia Medicinal Low Borosilicate Glass Tubes Product Portfolio
- 8.3.5 Antylia Recent Developments
- 8.4 DWK Life Sciences
- 8.4.1 DWK Life Sciences Company Information
- 8.4.2 DWK Life Sciences Business Overview
- 8.4.3 DWK Life Sciences Medicinal Low Borosilicate Glass Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 DWK Life Sciences Medicinal Low Borosilicate Glass Tubes Product Portfolio
- 8.4.5 DWK Life Sciences Recent Developments
- 8.5 GSC International
- 8.5.1 GSC International Company Information
- 8.5.2 GSC International Business Overview
- 8.5.3 GSC International Medicinal Low Borosilicate Glass Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 GSC International Medicinal Low Borosilicate Glass Tubes Product Portfolio
- 8.5.5 GSC International Recent Developments
- 8.6 Borosil
- 8.6.1 Borosil Company Information
- 8.6.2 Borosil Business Overview
- 8.6.3 Borosil Medicinal Low Borosilicate Glass Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Borosil Medicinal Low Borosilicate Glass Tubes Product Portfolio
- 8.6.5 Borosil Recent Developments
- 8.7 Nipro
- 8.7.1 Nipro Company Information
- 8.7.2 Nipro Business Overview
- 8.7.3 Nipro Medicinal Low Borosilicate Glass Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Nipro Medicinal Low Borosilicate Glass Tubes Product Portfolio
- 8.7.5 Nipro Recent Developments
- 8.8 Linuo
- 8.8.1 Linuo Company Information
- 8.8.2 Linuo Business Overview
- 8.8.3 Linuo Medicinal Low Borosilicate Glass Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Linuo Medicinal Low Borosilicate Glass Tubes Product Portfolio
- 8.8.5 Linuo Recent Developments
- 8.9 Shandong Pharmaceutical Glass
- 8.9.1 Shandong Pharmaceutical Glass Company Information
- 8.9.2 Shandong Pharmaceutical Glass Business Overview
- 8.9.3 Shandong Pharmaceutical Glass Medicinal Low Borosilicate Glass Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Shandong Pharmaceutical Glass Medicinal Low Borosilicate Glass Tubes Product Portfolio
- 8.9.5 Shandong Pharmaceutical Glass Recent Developments
- 8.10 Chongqing Zhengchuan Pharmaceutical Packaging
- 8.10.1 Chongqing Zhengchuan Pharmaceutical Packaging Company Information
- 8.10.2 Chongqing Zhengchuan Pharmaceutical Packaging Business Overview
- 8.10.3 Chongqing Zhengchuan Pharmaceutical Packaging Medicinal Low Borosilicate Glass Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Chongqing Zhengchuan Pharmaceutical Packaging Medicinal Low Borosilicate Glass Tubes Product Portfolio
- 8.10.5 Chongqing Zhengchuan Pharmaceutical Packaging Recent Developments
- 8.11 Chongqing Beiyuan Glass
- 8.11.1 Chongqing Beiyuan Glass Company Information
- 8.11.2 Chongqing Beiyuan Glass Business Overview
- 8.11.3 Chongqing Beiyuan Glass Medicinal Low Borosilicate Glass Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Chongqing Beiyuan Glass Medicinal Low Borosilicate Glass Tubes Product Portfolio
- 8.11.5 Chongqing Beiyuan Glass Recent Developments
- 8.12 Taian Youlyy Industrial
- 8.12.1 Taian Youlyy Industrial Company Information
- 8.12.2 Taian Youlyy Industrial Business Overview
- 8.12.3 Taian Youlyy Industrial Medicinal Low Borosilicate Glass Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Taian Youlyy Industrial Medicinal Low Borosilicate Glass Tubes Product Portfolio
- 8.12.5 Taian Youlyy Industrial Recent Developments
- 8.13 Chongqing Wanzhou Shenyu Medicinal Glass
- 8.13.1 Chongqing Wanzhou Shenyu Medicinal Glass Company Information
- 8.13.2 Chongqing Wanzhou Shenyu Medicinal Glass Business Overview
- 8.13.3 Chongqing Wanzhou Shenyu Medicinal Glass Medicinal Low Borosilicate Glass Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Chongqing Wanzhou Shenyu Medicinal Glass Medicinal Low Borosilicate Glass Tubes Product Portfolio
- 8.13.5 Chongqing Wanzhou Shenyu Medicinal Glass Recent Developments
- 8.14 Puyang Xinhe Industry Development
- 8.14.1 Puyang Xinhe Industry Development Company Information
- 8.14.2 Puyang Xinhe Industry Development Business Overview
- 8.14.3 Puyang Xinhe Industry Development Medicinal Low Borosilicate Glass Tubes Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Puyang Xinhe Industry Development Medicinal Low Borosilicate Glass Tubes Product Portfolio
- 8.14.5 Puyang Xinhe Industry Development Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Medicinal Low Borosilicate Glass Tubes Value Chain Analysis
- 9.1.1 Medicinal Low Borosilicate Glass Tubes Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Medicinal Low Borosilicate Glass Tubes Production Mode & Process
- 9.2 Medicinal Low Borosilicate Glass Tubes Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Medicinal Low Borosilicate Glass Tubes Distributors
- 9.2.3 Medicinal Low Borosilicate Glass Tubes Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst